BR112022005992A2 - Fármaco contendo derivado de heterociclideno acetamida - Google Patents

Fármaco contendo derivado de heterociclideno acetamida

Info

Publication number
BR112022005992A2
BR112022005992A2 BR112022005992A BR112022005992A BR112022005992A2 BR 112022005992 A2 BR112022005992 A2 BR 112022005992A2 BR 112022005992 A BR112022005992 A BR 112022005992A BR 112022005992 A BR112022005992 A BR 112022005992A BR 112022005992 A2 BR112022005992 A2 BR 112022005992A2
Authority
BR
Brazil
Prior art keywords
heterocyclidene
derivative
drug containing
acetamide
present
Prior art date
Application number
BR112022005992A
Other languages
English (en)
Portuguese (pt)
Inventor
Shinya Kobayashi
Takeshi Tarui
Original Assignee
Mochida Pharm Co Ltd
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd, Senju Pharma Co filed Critical Mochida Pharm Co Ltd
Publication of BR112022005992A2 publication Critical patent/BR112022005992A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112022005992A 2019-10-04 2020-10-02 Fármaco contendo derivado de heterociclideno acetamida BR112022005992A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019184053 2019-10-04
PCT/JP2020/037548 WO2021066144A1 (ja) 2019-10-04 2020-10-02 ヘテロシクリデンアセトアミド誘導体含有医薬

Publications (1)

Publication Number Publication Date
BR112022005992A2 true BR112022005992A2 (pt) 2022-06-21

Family

ID=75338162

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022005992A BR112022005992A2 (pt) 2019-10-04 2020-10-02 Fármaco contendo derivado de heterociclideno acetamida

Country Status (17)

Country Link
US (3) US12533337B2 (cg-RX-API-DMAC7.html)
EP (2) EP4545095A3 (cg-RX-API-DMAC7.html)
JP (4) JP7025094B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220078604A (cg-RX-API-DMAC7.html)
CN (1) CN114585357A (cg-RX-API-DMAC7.html)
AU (2) AU2020361093B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022005992A2 (cg-RX-API-DMAC7.html)
CA (1) CA3156484A1 (cg-RX-API-DMAC7.html)
DK (1) DK4043014T3 (cg-RX-API-DMAC7.html)
ES (1) ES3031607T3 (cg-RX-API-DMAC7.html)
HU (1) HUE072085T2 (cg-RX-API-DMAC7.html)
MX (2) MX2022004027A (cg-RX-API-DMAC7.html)
MY (1) MY207759A (cg-RX-API-DMAC7.html)
PH (1) PH12022550805A1 (cg-RX-API-DMAC7.html)
PL (1) PL4043014T3 (cg-RX-API-DMAC7.html)
PT (1) PT4043014T (cg-RX-API-DMAC7.html)
WO (1) WO2021066144A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022005992A2 (pt) 2019-10-04 2022-06-21 Mochida Pharm Co Ltd Fármaco contendo derivado de heterociclideno acetamida
JP7175431B1 (ja) 2021-03-30 2022-11-18 千寿製薬株式会社 ヘテロシクリデンアセトアミド誘導体含有懸濁液
EP4595959A1 (en) * 2022-09-29 2025-08-06 Senju Pharmaceutical Co., Ltd. Sterilized heterocyclidene-acetamide-derivative-containing suspension
EP4595960A1 (en) 2022-09-29 2025-08-06 Senju Pharmaceutical Co., Ltd. Combination preparation containing heterocyclidene acetamide derivative

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5621566A (en) 1979-08-01 1981-02-28 Alpha- Shokuhin Kk Preparation of bifun from homegrown rice and apparatus used for it
RU2451014C2 (ru) 2005-07-22 2012-05-20 Мотида Фармасьютикал Ко., Лтд. Новое производное гетероциклиден ацетамида
JP4754566B2 (ja) 2005-07-22 2011-08-24 持田製薬株式会社 新規なヘテロシクリデンアセトアミド誘導体
CN101228131B (zh) 2005-07-22 2013-01-09 持田制药株式会社 新的杂环亚基乙酰胺衍生物
TW200927192A (en) * 2007-11-19 2009-07-01 Alcon Res Ltd Use of TRPV1 receptor antagonists for treating dry eye and ocular pain
US20100210682A1 (en) * 2009-02-19 2010-08-19 Abbott Laboratories Repeated Dosing of TRPV1 Antagonists
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
WO2012045729A1 (en) * 2010-10-05 2012-04-12 Glaxo Group Limited Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists
GB201215857D0 (en) * 2012-09-05 2012-10-24 Sylentis Sau siRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions
JP6230743B1 (ja) 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
JP7373909B2 (ja) 2018-04-06 2023-11-06 株式会社シマノ 変速制御装置および変速システム
BR112022005992A2 (pt) 2019-10-04 2022-06-21 Mochida Pharm Co Ltd Fármaco contendo derivado de heterociclideno acetamida

Also Published As

Publication number Publication date
PT4043014T (pt) 2025-06-09
MX2025005474A (es) 2025-06-02
AU2020361093B2 (en) 2026-04-30
JP2023011735A (ja) 2023-01-24
JP7801201B2 (ja) 2026-01-16
AU2026202464A1 (en) 2026-04-16
US20260124171A1 (en) 2026-05-07
JP2022065024A (ja) 2022-04-26
JP7025094B2 (ja) 2022-02-24
KR20220078604A (ko) 2022-06-10
EP4545095A2 (en) 2025-04-30
JP2026042857A (ja) 2026-03-11
JP7248836B2 (ja) 2023-03-29
EP4043014A1 (en) 2022-08-17
EP4545095A3 (en) 2025-07-02
JPWO2021066144A1 (ja) 2021-12-02
PL4043014T3 (pl) 2025-08-11
CN114585357A (zh) 2022-06-03
US20250134854A1 (en) 2025-05-01
EP4043014B1 (en) 2025-03-19
US20220370404A1 (en) 2022-11-24
PH12022550805A1 (en) 2023-10-02
WO2021066144A1 (ja) 2021-04-08
US12502375B2 (en) 2025-12-23
MX2022004027A (es) 2022-07-19
HUE072085T2 (hu) 2025-10-28
MY207759A (en) 2025-03-17
DK4043014T3 (da) 2025-06-23
US12533337B2 (en) 2026-01-27
CA3156484A1 (en) 2021-04-08
EP4043014A4 (en) 2023-10-11
ES3031607T3 (en) 2025-07-09
AU2020361093A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
UY38001A (es) Compuestos que inhiben las proteínas ras mutantes g12c
CY1124652T1 (el) Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες
BR112018072570A2 (pt) piperidinas como inibidores de menina
MX2025005474A (es) Farmaco farmaceutico que contiene derivado de heterocicliden acetamida
UY39723A (es) Modulador del regulador de conductancia transmembrana de fibrosis quística, composiciones farmacéuticas, métodos de tratamiento y proceso para producir el modulador
BR112022016382A2 (pt) Triptaminas específicas para o uso no tratamento de doenças do humor
SA521422143B1 (ar) 15-pgdh مثبط
CY1124432T1 (el) Φαρμακευτικες συνθεσεις που αποτελουν ν-(3,5-διμεθοδυφαινυλ)-ν'-(1-μεθυλαιθυλ)-ν-[3-(1--μεθυλ-1η-πυραζολ-4-υλ)κινοοξαλιν-6-υλ]αιθανο-1,2-διαμινη
BR112023014973A2 (pt) Derivados de urolitina e métodos de uso dos mesmos
MX382068B (es) Derivados aromáticos de sulfonamida.
CL2020000122A1 (es) Métodos de tratamiento para la fibrosis quística.
UY38403A (es) Moduladores de la alfa-1 antitripsina
CL2019001077A1 (es) Derivados de 6,7,8,9-tetrahidro-3h-pirazolo[4,3-f] isoquinolina útiles en el tratamiento del cáncer.
MX2020007947A (es) Inhibidores de erbb/btk.
BR112018011475A2 (pt) compostos e métodos para modulação de quinase e indicação para a mesma
MX392213B (es) Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano.
MX2023014946A (es) Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal.
BR112017011316A2 (pt) derivados heterocíclicos e uso destes
MX385578B (es) Moduladores de canales de kv3 para tratar dolor.
MX390077B (es) Inhibidor de bromodominio.
MX388378B (es) Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos.
ZA202006071B (en) Antiproliferation compounds and uses thereof
CO2019002517A2 (es) Inhibidores de dopamina–β–hidroxilasa
AR115783A1 (es) DERIVADOS DE TIADIAZINAS, UN MÉTODO PARA SU PREPARACIÓN, COMPOSICIÓN Y COMBINACIÓN FARMACÉUTICA QUE LOS COMPRENDEN Y EL USO DE LOS MISMOS EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS AL RECEPTOR NICOTÍNICO DE ACETILCOLINA a7
AR114418A1 (es) Compuesto cíclico de metilactama y su utilización farmacéutica

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B154 Notification of filing of divisional application [chapter 15.50 patent gazette]

Free format text: O PEDIDO FOI DIVIDIDO NO BR122025000958-0 PROTOCOLO 870250004096 EM 17/01/2025 15:25.